...
首页> 外文期刊>Oncology: International Journal of Cancer Research and Treatment >Prognostic evaluation of preoperative thermochemoradiotherapy for n(3) cervical lymph node metastases of oral cancer.
【24h】

Prognostic evaluation of preoperative thermochemoradiotherapy for n(3) cervical lymph node metastases of oral cancer.

机译:口腔癌n(3)颈淋巴结转移的术前热化学放疗的预后评估。

获取原文
获取原文并翻译 | 示例
           

摘要

Objective: The purpose of this study was to evaluate the clinical efficacy, histopathological efficacy, and response to preoperative thermochemoradiotherapy for N(3) cervical lymph node metastases of oral cancer. Methods: Preoperative thermochemoradiotherapy was performed in 8 patients with oral cancer and N(3) cervical lymph node metastasis. These patients underwent four-weekly sessions of hyperthermia, combined with radiotherapy (40 Gy) as well as chemotherapy with cisplatin (CDDP; 100 mg/m(2)), all prior to surgery. Radical neck dissection was performed 4 weeks after completion of preoperative thermochemoradiotherapy. Results: The preoperative treatment of cervical lymph node metastases yielded a partial response in 6 patients, while 2 patients demonstrated no change. Histopathologically, grade III was detected in 1, grade IIb in 4 and grade IIa in 3 patients after surgery, according to the criteria of Shimosato. The follow-up period ranged from 13 to 64 months (mean 34). Of the 8 patients, 2 died (1 of lymph node metastasis and 1 had metastasis to a distant site), and 6 patients were alive at the last follow-up, with the longest postoperative disease-free survival being 63 months. The 5-year cumulative survival rate was 70.0%. Conclusion: These results indicate that preoperative thermochemoradiotherapy is a promising modality for patients with N(3) cervical lymph node metastasis of oral cancer.
机译:目的:本研究旨在评估口腔癌N(3)颈淋巴结转移的临床疗效,组织病理学疗效以及对术前热化学放疗的反应。方法:对8例口腔癌和N(3)颈淋巴结转移的患者进行术前热化学放疗。这些患者均在手术前进行了为期四周的热疗,并结合放疗(40 Gy)和顺铂化疗(CDDP; 100 mg / m(2))。术前热化学放疗完成后4周进行根治性颈清扫术。结果:6例患者的术前治疗子宫颈淋巴结转移产生了部分缓解,而2例患者无变化。根据Shimosato的标准,在组织病理学上,手术后1例IIb分级为4级,IIIa例为3例。随访时间为13到64个月(平均34个月)。在8例患者中,有2例死亡(1例淋巴结转移和1例转移到远处),最后一次随访时有6例存活,术后无病生存时间最长为63个月。 5年累计生存率为70.0%。结论:这些结果表明术前热化学放疗是口腔癌N(3)颈淋巴结转移患者的一种有前途的方式。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号